Humoral immune response to messenger RNA COVID-19 vaccines among patients with inflammatory bowel disease
MD Kappelman, KN Weaver, M Boccieri… - …, 2021 - gastrojournal.org
Methods The Partnership to Report Effectiveness of Vaccination in populations Excluded
from iNitial Trials of COVID (PREVENT-COVID) is a prospective, observational, cohort study
of patients with IBD who have received any COVID-19 vaccine granted Emergency Use
Authorization in the United States. Eligibility criteria were a diagnosis of IBD, receipt of 1 or
more doses of any COVID-19 vaccine within the prior 90 days, age 16 years or older, US
residence, access to the internet and ability to complete surveys in English, and willingness …
from iNitial Trials of COVID (PREVENT-COVID) is a prospective, observational, cohort study
of patients with IBD who have received any COVID-19 vaccine granted Emergency Use
Authorization in the United States. Eligibility criteria were a diagnosis of IBD, receipt of 1 or
more doses of any COVID-19 vaccine within the prior 90 days, age 16 years or older, US
residence, access to the internet and ability to complete surveys in English, and willingness …
